Prolgolimab Chemical Properties

form 

Liquid

color 

Colorless to light yellow

Prolgolimab Usage And Synthesis

Uses

Prolgolimab (BCD-100) is a human IgG1 anti-PD-1 monoclonal antibody containing the Fc-silencing 'LALA' mutation. Prolgolimab can be used for the research of advanced melanoma[1].

References

[1] Tjulandin S, et, al. Novel PD-1 inhibitor prolgolimab: expanding non-resectable/metastatic melanoma therapy choice. Eur J Cancer. 2021 May;149:222-232. DOI:10.1016/j.ejca.2021.02.030

Prolgolimab(2093956-19-3)Related Product Information

• Lesofavumab
• Suvratoxumab
• Lacnotuzumab
• Lintuzumab
• Berlimatoxumab
• Faricimab
• Teropavimab
• Gontivimab
• Amubarvimab
• Immunoglobulin G2/G4, anti-(human complement C5) (human-Mus musculus ALXN1210 heavy chain), disulfide with human-Mus musculus ALXN1210 κ-chain, dimer